Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

September 08, 2023 00:34:29
Episode Cover

Post-Arrest Care Updates - Are Mild Hypercapnia and a Pan-CT Protocol Useful?

Care of the patient with ROSC following OHCA can be complex and typically includes a protocolized approach to optimizing oxygenation, ventilation, hemodynamics, early cardiac...

Listen

Episode 0

August 24, 2017 00:25:06
Episode Cover

Hyponatremic Encephalopathy

Hyponatremia is one of the most common electrolyte disorders encountered in emergency medicine and critical care.  Patients with hyponatremic encephalopathy represent a severe form...

Listen

Episode 0

June 07, 2017 00:26:02
Episode Cover

Intubating & Ventilating the Obese Patient

Rory Spiegel and Ken Butler join the podcast to discuss critical issues in intubating and ventilating the obese patient.  What physiologic changes do you...

Listen